The effect of vitamin E, probucol, and lovastatin on oxidative status and aortic fatty lesions in hyperlipidemic-diabetic hamsters.

[1]  W. Palinski,et al.  Extent of antioxidant protection of plasma LDL is not a predictor of the antiatherogenic effect of antioxidants. , 1997, Journal of lipid research.

[2]  T. Saldeen,et al.  Preservation of endogenous antioxidant activity and inhibition of lipid peroxidation as common mechanisms of antiatherosclerotic effects of vitamin E, lovastatin and amlodipine. , 1997, Journal of the American College of Cardiology.

[3]  A. Barnett,et al.  Antioxidant status in patients with uncomplicated insulin‐dependent and non‐insulin‐dependent diabetes mellitus , 1997, European journal of clinical investigation.

[4]  A. Chait,et al.  Mechanisms of enhanced macrophage apoE secretion by oxidized LDL. , 1997, Journal of lipid research.

[5]  O. Hussein,et al.  Reduced susceptibility of low density lipoprotein (LDL) to lipid peroxidation after fluvastatin therapy is associated with the hypocholesterolemic effect of the drug and its binding to the LDL. , 1997, Atherosclerosis.

[6]  G. Shen,et al.  Oxidative modification enhances lipoprotein(a)-induced overproduction of plasminogen activator inhibitor-1 in cultured vascular endothelial cells. , 1997, Atherosclerosis.

[7]  M. Wilson,et al.  Formation of oxysterols during oxidation of low density lipoprotein by peroxynitrite, myoglobin, and copper. , 1996, Journal of lipid research.

[8]  P. Wilson,et al.  Lipoproteins, apolipoproteins, and low-density lipoprotein size among diabetics in the Framingham offspring study. , 1996, Metabolism: clinical and experimental.

[9]  R. Bucala,et al.  Effect of alpha-tocopherol on LDL oxidation and glycation: in vitro and in vivo studies. , 1996, Journal of lipid research.

[10]  S. Grundy,et al.  RRR-alpha-tocopheryl acetate supplementation at pharmacologic doses decreases low-density-lipoprotein oxidative susceptibility but not protein glycation in patients with diabetes mellitus. , 1996, The American journal of clinical nutrition.

[11]  P. Reaven.  Dietary and pharmacologic regimens to reduce lipid peroxidation in non-insulin-dependent diabetes mellitus. , 1995, The American journal of clinical nutrition.

[12]  H. Nawata,et al.  Glycation accelerates the oxidation of low density lipoprotein by copper ions. , 1995, Endocrine journal.

[13]  J. Ordovás,et al.  Lovastatin inhibits diet induced atherosclerosis in F1B golden Syrian hamsters. , 1995, Atherosclerosis.

[14]  I. Jialal,et al.  The Effect of α-Tocopherol Supplementation on LDL Oxidation: A Dose-Response Study , 1995 .

[15]  G. Bellomo,et al.  Autoantibodies Against Oxidatively Modified Low-Density Lipoproteins in NIDDM , 1995, Diabetes.

[16]  R. Galassi,et al.  Increased susceptibility to lipid oxidation of low-density lipoproteins and erythrocyte membranes from diabetic patients. , 1994, Metabolism: clinical and experimental.

[17]  F. Ursini,et al.  Analysis of plasma cholesterol oxidation products using gas- and high-performance liquid chromatography/mass spectrometry. , 1994, Free radical biology & medicine.

[18]  T. Hirano,et al.  Hyperlipidemia in streptozocin-diabetic hamsters as a model for human insulin-deficient diabetes: comparison to streptozocin-diabetic rats. , 1994, Metabolism: clinical and experimental.

[19]  S. Povoski,et al.  Induction of diabetes mellitus in Syrian golden hamsters using stored equilibrium solutions of streptozotocin. , 1993, Laboratory animal science.

[20]  E. Rimm,et al.  Vitamin E consumption and the risk of coronary heart disease in men. , 1993, The New England journal of medicine.

[21]  J. Manson,et al.  Vitamin E consumption and the risk of coronary disease in women. , 1993, The New England journal of medicine.

[22]  H. Tada,et al.  Effects of Probucol on Impaired Cardiac Performance and Lipid Metabolism in Streptozotocin‐Induced Diabetic Rats , 1992, Journal of cardiovascular pharmacology.

[23]  R. Gregg,et al.  Inhibition of fatty acid synthesis decreases very low density lipoprotein secretion in the hamster. , 1992, Journal of lipid research.

[24]  Y. Arad,et al.  Effects of lovastatin therapy on very-low-density lipoprotein triglyceride metabolism in subjects with combined hyperlipidemia: evidence for reduced assembly and secretion of triglyceride-rich lipoproteins. , 1992, Metabolism: clinical and experimental.

[25]  M. Taskinen,et al.  Abnormalities of low density lipoproteins in normolipidemic type II diabetic and nondiabetic patients with coronary artery disease. , 1992, Journal of lipid research.

[26]  Y. Matsuzawa,et al.  Probucol and atherosclerosis in the Watanabe heritable hyperlipidemic rabbit--long-term antiatherogenic effect and effects on established plaques. , 1992, Atherosclerosis.

[27]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[28]  M. Cybulsky,et al.  Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis. , 1991, Science.

[29]  D. Giugliano,et al.  Vitamin E Reduction of Protein Glycosylation in Diabetes: New Prospect for Prevention of Diabetic Complications? , 1991, Diabetes Care.

[30]  L. Niskanen,et al.  5-year incidence of atherosclerotic vascular disease in relation to general risk factors, insulin level, and abnormalities in lipoprotein composition in non-insulin-dependent diabetic and nondiabetic subjects. , 1990, Circulation.

[31]  S. Grundy,et al.  Physiologic levels of ascorbate inhibit the oxidative modification of low density lipoprotein. , 1990, Atherosclerosis.

[32]  K. Bruckdorfer,et al.  Native and oxidized low‐density lipoproteins have different inhibitory effects on endothelium‐derived relaxing factor in the rabbit aorta , 1990, British journal of pharmacology.

[33]  G. Walldius,et al.  Effect of probucol treatment on the susceptibility of low density lipoprotein isolated from hypercholesterolemic patients to become oxidatively modified in vitro. , 1990, Atherosclerosis.

[34]  S. Jain,et al.  Erythrocyte Membrane Lipid Peroxidation and Glycosylated Hemoglobin in Diabetes , 1989, Diabetes.

[35]  E. Schaefer,et al.  Postprandial Changes in the Plasma Concentration of α- and γ-Tocopherol in Human Subjects Fed a Fat-Rich Meal Supplemented with Fat-Soluble Vitamins , 1989 .

[36]  R. Morin,et al.  The role of cholesterol oxidation products in the pathogenesis of atherosclerosis. , 1989, Annals of clinical and laboratory science.

[37]  R. N. Brogden,et al.  Probucol , 1989, Drugs.

[38]  T. Carew,et al.  In vivo inhibition of foam cell development by probucol in Watanabe rabbits. , 1988, The American journal of cardiology.

[39]  D. Morel,et al.  Lipoprotein oxidation and cytotoxicity: effect of probucol on streptozotocin-treated rats. , 1988, The American journal of cardiology.

[40]  J. Dietschy,et al.  Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster. , 1988, The Journal of clinical investigation.

[41]  A. Radu,et al.  The hyperlipidemic hamster as a model of experimental atherosclerosis. , 1987, Atherosclerosis.

[42]  E. Schaefer,et al.  Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions. , 1987, Clinica chimica acta; international journal of clinical chemistry.

[43]  L. Cook,et al.  Regulation of gallbladder cholesterol concentration in the hamster. Role of hepatic cholesterol level. , 1986, Biochimica et biophysica acta.

[44]  D. Morel,et al.  Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid. , 1983, Journal of lipid research.

[45]  M. Takayama,et al.  A new enzymatic method for determination of serum choline-containing phospholipids. , 1977, Clinica chimica acta; international journal of clinical chemistry.

[46]  W. E. Neeley.  Simple automated determination of serum or plasma glucose by a hexokinase-glucose-6 -phosphate dehydrogenase method. , 1972, Clinical chemistry.

[47]  K. Thompson,et al.  Dietary antioxidants do not reduce fatty streak formation in the C57BL/6 mouse atherosclerosis model. , 1998, Arteriosclerosis, thrombosis, and vascular biology.

[48]  D. Armstrong,et al.  Lipid peroxidation and retinopathy in streptozotocin-induced diabetes. , 1991, Free radical biology & medicine.